medline.ch Gynäkologie Mammae

	(68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study. J Nucl Med Gao S, Zhang Z, Shi C, Cheng C, Ma X, Zhao X, Liu Y. PMID: 42562610 [PubMed - as supplied by publisher]
	Moderating Role of Perceived Neighborhood Environment on Physical Activity and BMI Outcomes of a Diet and Physical Activity Intervention Among Latina Breast Cancer Survivors. J Phys Act Health Hill CM, Rillamas-Sun E, Marín-Chollom AM, Ulanday KT, Koch PA, Contento IR, Ogden Gaffney A, Hershman DL, Greenlee H. PMID: 42562369 [PubMed - as supplied by publisher]
	Inflammatory breast cancer: improving research and care through the integration of preclinical evidence and technological advances. Crit Rev Oncol Hematol Nicolo E, Manai M, Soliman A, Reduzzi C, Cristofanilli M. PMID: 42562246 [PubMed - as supplied by publisher]
	F11 Receptor/Junctional Adhesion Molecule-A: a novel therapeutic target in breast cancer. Biochimie Bednarek R, . PMID: 42562075 [PubMed - as supplied by publisher]
	Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N. Cell Rep Med Li JJ, Ma LX, Ji P, Chen L, Wu J, Liu GY, Hou YF, Di GH, Hu Z, Jiang YZ, Fan L, Wang ZH, Yu KD, Zhi-Ming Shao. PMID: 42561949 [PubMed - as supplied by publisher]
	Diagnostic specificity of the novel marker TRPS1 compared with traditional breast-specific markers in differentiating metastatic breast carcinoma from adrenal neoplasms. Ann Diagn Pathol Lobo A, Wu DJ, Sangoi AR. PMID: 42561593 [PubMed - as supplied by publisher]
	WDCN: a comprehensive neural network based approach for estimating breast cancer risk. Brief Bioinform Xu H, Zhang G, Lin H, Grosser M, Lu J. PMID: 42561150 [PubMed - indexed for MEDLINE]
	Combined prediction of anthracycline-induced cardiotoxicity in patients with breast cancer using neutrophil-to-lymphocyte ratio and left atrial reservoir strain: A prospective observational study. J Int Med Res Shao P, Wu Z, Liu X, Yao C, Li Y, Zhang B, Liu Z. PMID: 42561098 [PubMed - indexed for MEDLINE]
	A proof-of-concept study of optical tissue sensing during vacuum-assisted breast biopsy procedures. Minim Invasive Ther Allied Technol Feenstra L, Drukker CA, Van Duijnhoven F, Mann R, Poelman E, Bruining A, Da Silva Guimaraes M, Dasht Bozorg B, Ruers TJM. PMID: 42560820 [PubMed - as supplied by publisher]
	Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol Karsten MM, Gebert P, Pross T, Hage AM, Dordevic AD, Stephan S, Kühn F, Doppelbauer L, Blohmer JU, Fischer F, Rose M, Pöhlmann A, Materne B, Petersen MA, Pauler L, Ferencz J, Wesselmann S, Breidenbach C, Grittner U, Kowalski C. PMID: 42560727 [PubMed - as supplied by publisher]
	Integrative analysis of TCGA data identifies hsa-miR-200a as a breast cancer-associated microRNA biomarker with exploratory serum validation. Genes Genomics Park K, Kim EY, Lee EJ, Nam H, Park HW, Lee EH, Kim H, Lee KE, Jeon D, Kim J. PMID: 42560646 [PubMed - as supplied by publisher]
	Prognostic value of post-neoadjuvant pathological response and residual disease in early breast cancer: a real-world cohort study. Clin Transl Oncol Ferro A, Campora M, Eccher C, Lorenzi M, Biondi R, Caldara A, Cantarelli S, Campregher M, Carbone G, De Lisi D, Dipasquale M, Lazzeri S, Monteverdi S, Armatura G, De Rose F, Gori S, Valentini M, Caffo O. PMID: 42560581 [PubMed - as supplied by publisher]
	CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging Opportunities. Target Oncol Chinea L, Hauer C, Pal K, Chang HL, Chan IS. PMID: 42560566 [PubMed - as supplied by publisher]
	P-VERIFY: Real-World Comparative Overall Survival and Progression-Free Survival of CDK4/6 Inhibitors Plus an Aromatase Inhibitor in Patients with HR+/HER2- Metastatic Breast Cancer in the USA-A Vodcast. Target Oncol Rugo HS, Ryan JC. PMID: 42560565 [PubMed - as supplied by publisher]
	Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018-2023). Breast Cancer Res Treat Sun W, Li H, Zhao X, Hu S, Qi H, Jin S, Zhang W, Zhao F. PMID: 42560548 [PubMed - indexed for MEDLINE]
	Commissioning and clinical positioning assessment of a novel surface-guided radiation therapy (SGRT) system at a C-Arm linear accelerator. J Appl Clin Med Phys Looe HK, Bartner NFH, Poppe B, Willborn KC. PMID: 42560082 [PubMed - indexed for MEDLINE]
	Direct Hospital Costs of Ambulatory versus Inpatient Needle-Localized Breast Biopsy: A Retrospective Cohort Study. Breast Care (Basel) Thong-Aek CS, Sungworawongpana C, Samphao S, Mahattanobon S, Noonpradej S, Chaochankit W. PMID: 42559575 [PubMed - as supplied by publisher]
	Trop2-targeted PET/CT imaging with (68)Ga-MY6349 improves diagnostic accuracy and influences clinical management in breast cancer. Theranostics Yu L, Zhao L, Zeng R, Su Y, Wu Z, Yu S, Li Y, Fu H, Guo W, Sun Y, Gao H, Sun L, Wu H, Ye F, Wang F, Chen H. PMID: 42559486 [PubMed - indexed for MEDLINE]
	Liquid biopsy in breast cancer: current biomarker platforms and clinical applications. Explor Target Antitumor Ther Podder PS, Bhadra D, Martinelli C, Cortellino S, Giordano A, Cinti S. PMID: 42558869 [PubMed]
	Informing mobile health strategies: Study of mobile phone ownership among rural women for breast cancer control in Ghana. Digit Health Boamah Mensah AB, Mensah KB, Agbeko AE, Mohammed A, Okyere J, Dodd C, Horvath K, Virnig B, Clegg-Lamptey JN, Kulasingam S. PMID: 42558772 [PubMed]

Artikel 1 - 20 / 220853

Seite 1 von 11043

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung